Literature DB >> 7588160

The ontogeny of the glucose-6-phosphatase enzyme in human embryonic and fetal red blood cells.

R Hume1, S Pazouki, A Hallas, A Burchell.   

Abstract

We have shown for the first time that the microsomal glucose-6-phosphatase enzyme protein is present in human embryonic and fetal red blood cells and the ontogeny of its expression has been determined. In the earliest embryos, red cells are predominantly of the primitive megaloblastic type. Circulating red cells in the primitive megaloblastic series are predominantly nucleated and glucose-6-phosphatase immunopositive. Non-nucleated, immunoreactive megaloblastic cells are in a minority. In fetuses > 12 weeks gestation, the erythrocytes are of the definitive normoblastic series and in the transitional period of switch-over in late embryonic-early fetal life, up to 30% of glucose-6-phosphatase immunopositive cells are definitive normoblastic in type, with a variable contribution from nucleated and non-nucleated cells. Thereafter, the number of immunopositive cells in the definitive normoblastic series decreases such that after 12 weeks gestation it is less than 5%. The fact that a predominantly hepatic protein in adults (glucose-6-phosphatase) is present in embryonic and fetal red blood cells, particularly nucleated red cells, raises the possibility of diagnosis of disorders of liver protein expression in nucleated fetal red cells isolated from the first trimester maternal circulation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7588160     DOI: 10.1016/0378-3782(95)01626-e

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  2 in total

1.  Isolation of fetal nucleated red blood cells from maternal blood.

Authors:  L Zou; X Ye; K Xu; J Zhu
Journal:  J Tongji Med Univ       Date:  2000

Review 2.  Hypoglycemia in the preterm neonate: etiopathogenesis, diagnosis, management and long-term outcomes.

Authors:  Anudeepa Sharma; Ajuah Davis; Prem S Shekhawat
Journal:  Transl Pediatr       Date:  2017-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.